Chularat Hospital Public Company Limited

SET:CHG Stock Report

Market Cap: ฿21.2b

Chularat Hospital Valuation

Is CHG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CHG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
฿1.83
Fair Value
5.7% overvalued intrinsic discount
10
Number of Analysts

Below Fair Value: CHG (THB1.93) is trading above our estimate of fair value (THB1.83)

Significantly Below Fair Value: CHG is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CHG?

Key metric: As CHG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CHG. This is calculated by dividing CHG's market cap by their current earnings.
What is CHG's PE Ratio?
PE Ratio22x
Earnings฿965.22m
Market Cap฿21.23b

Price to Earnings Ratio vs Peers

How does CHG's PE Ratio compare to its peers?

The above table shows the PE ratio for CHG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average27x
RAM Ramkhamhaeng Hospital
30.2x28.63%฿22.0b
VIBHA Vibhavadi Medical Center
30.9xn/a฿21.6b
SKR Sikarin
20.8xn/a฿13.8b
PR9 Praram 9 Hospital
26.1x10.97%฿18.6b
CHG Chularat Hospital
22x11.42%฿21.2b

Price-To-Earnings vs Peers: CHG is good value based on its Price-To-Earnings Ratio (22x) compared to the peer average (27x).

Price to Earnings Ratio vs Industry

How does CHG's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
CHG 22.0xIndustry Avg. 18.0xNo. of Companies8PE01020304050+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CHG is expensive based on its Price-To-Earnings Ratio (22x) compared to the TH Healthcare industry average (18.4x).

Price to Earnings Ratio vs Fair Ratio

What is CHG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CHG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22x
Fair PE Ratio19.7x

Price-To-Earnings vs Fair Ratio: CHG is expensive based on its Price-To-Earnings Ratio (22x) compared to the estimated Fair Price-To-Earnings Ratio (19.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CHG forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current฿1.93
฿2.80
+44.82%
12.59%฿3.70฿2.50n/a10
May ’26฿1.78
฿2.80
+57.02%
12.59%฿3.70฿2.50n/a10
Apr ’26฿1.68
฿2.88
+71.13%
10.91%฿3.70฿2.52n/a10
Mar ’26฿2.16
฿3.20
+48.15%
9.06%฿3.70฿2.80n/a10
Feb ’26฿2.18
฿3.23
+48.17%
8.08%฿3.70฿2.80n/a10
Jan ’26฿2.44
฿3.33
+36.59%
7.71%฿3.80฿3.00n/a11
Dec ’25฿2.64
฿3.33
+26.24%
7.71%฿3.80฿3.00n/a11
Nov ’25฿2.90
฿3.32
+14.34%
7.72%฿3.80฿3.00n/a10
Oct ’25฿2.74
฿3.25
+18.65%
7.07%฿3.60฿3.00n/a9
Sep ’25฿2.56
฿3.27
+27.56%
8.25%฿3.70฿2.93n/a9
Aug ’25฿2.48
฿3.37
+36.02%
11.44%฿3.90฿2.70n/a9
Jul ’25฿2.56
฿3.33
+30.23%
13.75%฿3.90฿2.50n/a10
Jun ’25฿2.94
฿3.33
+13.40%
13.75%฿3.90฿2.50n/a10
May ’25฿2.90
฿3.35
+15.45%
13.10%฿3.90฿2.50฿1.7810
Apr ’25฿2.94
฿3.35
+13.88%
13.10%฿3.90฿2.50฿1.6810
Mar ’25฿2.96
฿3.38
+14.12%
13.36%฿3.90฿2.50฿2.1610
Feb ’25฿3.02
฿3.43
+13.73%
12.80%฿3.90฿2.50฿2.1811
Jan ’25฿3.14
฿3.42
+8.84%
13.76%฿4.00฿2.50฿2.4412
Dec ’24฿2.88
฿3.41
+18.37%
13.67%฿4.00฿2.50฿2.6412
Nov ’24฿3.14
฿3.50
+11.60%
10.92%฿4.04฿2.55฿2.9012
Oct ’24฿3.26
฿3.59
+10.05%
12.64%฿4.40฿2.55฿2.7412
Sep ’24฿3.16
฿3.68
+16.36%
16.15%฿5.05฿2.55฿2.5613
Aug ’24฿2.90
฿3.79
+30.78%
14.58%฿5.05฿3.06฿2.4812
Jul ’24฿3.00
฿3.77
+25.69%
14.98%฿5.05฿3.06฿2.5612
Jun ’24฿3.16
฿3.90
+23.54%
14.72%฿5.05฿3.06฿2.9413
May ’24฿3.50
฿4.18
+19.38%
9.81%฿5.05฿3.40฿2.9013
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
฿2.80
Fair Value
30.9% undervalued intrinsic discount
10
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/13 04:29
End of Day Share Price 2025/05/13 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Chularat Hospital Public Company Limited is covered by 20 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charti PhrawphraikulBofA Global Research
Narumon EkasamutBualuang Securities PCL
Panjapon TaensricharoenBualuang Securities PCL